Previous Close | 3.1000 |
Open | 3.0900 |
Bid | 2.9200 x N/A |
Ask | 2.9500 x N/A |
Day's Range | 2.9500 - 3.1000 |
52 Week Range | 2.9500 - 3.9500 |
Volume | |
Avg. Volume | 22,401 |
Market Cap | 146.495M |
Beta (5Y Monthly) | 1.84 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Nov 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially.
Mustard-derived intellectual property portfolio has significantly advanced in quantity and scope.Patents have been filed across six continents.Patent portfolio has grown from 23 to 84 in three year period.Saskatoon, Saskatchewan--(Newsfile Corp. - March 8, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to report on the growth of its intellectual property portfolio (the "IP Portfolio") in both quantity and scope, particularly with